UnitedHealth Group said in a court filing it is working with Amedisys to identify potential buyers for at least 128 home ...

Recent developments in the legal battle over the planned $3.3 billion UnitedHealth Group (NYSE: UHG) acquisition of Amedisys (Nasdaq: AMED) have moved the ...

UnitedHealth Group and Amedisys outlined plans to divest a significant number of home health and hospice locations as they ...

UnitedHealth Group says the Justice Department’s antitrust challenge to its proposed $3.3 billion purchase of Amedisys is wrong on the merits and threatens to deprive consumers of benefits from ...

UnitedHealth Group said its motion to dismiss the DOJ lawsuit was moot after the agency cited which regions would be impacted ...

UnitedHealth Group has withdrawn its motion to dismiss the Justice Department’s ongoing antitrust challenge to a proposed acquisition, saying a government filing in late January provided information ...

UnitedHealth Group Inc. is withdrawing its motion to dismiss the Justice Department’s lawsuit seeking to block its $3.3 ...

In a report released on January 29, Whit Mayo from Leerink Partners reiterated a Hold rating on Amedisys (AMED – Research Report), with a price ...

UnitedHealth Group Inc. (NYSE: UNH) is dropping its motion to dismiss the U.S. Department of Justice’s (DOJ) antitrust lawsuit regarding the company’s ...

Amedisys' expected merger with UnitedHealth Group's Optum brings optimism to investors. Yet, a dull macroeconomic condition adds to the worry. In a regulatory filing, Amedisys (AMED) stated ...

According to Modern Healthcare, Humana has a five-step plan to improve its profit margins, including boosting its star ratings, stabilizing membership, and investing in primary care.

UnitedHealth Group says the Justice Department’s antitrust challenge to its proposed $3.3 billion purchase of Amedisys is wrong on the merits and threatens to deprive consumers of benefits from ...